Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related
deaths worldwide with rapidly growing incidence rates in the USA and Europe. Despite …

Background No consensus treatment has been reached for hepatocellular carcinoma (HCC)
with portal vein tumor thrombus (PVTT). Hepatic resection (HR) and transarterial …

Background Patients with intermediate-and advanced-stage hepatocellular carcinoma
(HCC) represent a highly heterogeneous patient collective with substantial differences in …

Objective: To examine whether tumor-selective infiltration, activation, and cytotoxic activity of
tumor infiltrating T lymphocytes (TIL) can be demonstrated in situ in colorectal cancer …

Background and objective To develop a machine-learning model by integrating clinical and
imaging modalities for predicting tumor response and survival of hepatocellular carcinoma …

Enrichment of toxicological elements in soils of high geologic background has a significant
effect on toxicity. The aim of this study was to assess the health risks associated with the …

Background Vascular invasion is a major determinant of survival outcomes after curative
resection for hepatocellular carcinoma (HCC) patients. This study was designed to …

Background & objective Transarterial chemoembolization (TACE) is recommended as the
first-line therapy for intermediate stage hepatocellular carcinoma (HCC) according to the …

Abstract Purpose of Review The purpose of the review is to summarize the latest
applications for embolotherapy in the management of patients with HCC according to BCLC …

Simple Summary Transarterial chemoembolization (TACE) is the treatment of choice for
patients with liver cancer without distant metastases or tumor growth into blood vessels. For …